Novavax originally showed its vaccine was safe and effective in a 30,000-person clinical trial. The FDA had been on track to ...

After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...

The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...

US regulators grant full approval to Novavax shot but sharply limit eligibility. New studies on heart risks required, raising ...

T he FDA issued an approval of Novavax’s COVID-19 vaccine, but with unusual restrictions, Lauran Neegaard of AP News reports. The FDA recently granted the company full approval ...

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and Drug Administration (FDA) has removed the ...

The FDA was on track to grant Novavax full approval by its April 1 target date, according to two people with direct knowledge of the situation who spoke on condition of anonymity to discuss ...

But we're working with the FDA. We plan on partnering with them ... And this isn't specific to Novavax, just in general. Are the authorities saying, hey, well, there needs to be a full-blown ...

The FDA is a massive agency charged with regulating ... Earlier this year, the Trump administration sought for drug manufacturer Novavax to commit to conducting a new clinical trial on its ...

People “don’t like the uncertainties,” he says. Most notable, the FDA did not approve Novavax’s peptide vaccine for SARS-CoV-2, which Makary has insisted must be tested again for efficacy.